Citations

Citations to this article as recorded by  

• Deep Learning Model Using Stool Pictures for Predicting Endoscopic Mucosal Inflammation in Patients With Ulcerative Colitis
  Jung Won Lee, Dongwon Woo, Kyeong Ok Kim, Eun Soo Kim, Sung Kook Kim, Hyun Seok Lee, Ben Kang, Yoo Jin Lee, Jeongseok Kim, Byung Ik Jang, Eun Young Kim, Hyeong Ho Jo, Yun Jin Chung, Hanjun Ryu, Soo-Kyung Park, Dong-Il Park, Hosang Yu, Sungmoon Jeong
  American Journal of Gastroenterology.2025; 120(1): 213.     CrossRef
• Effectiveness of Early Thiopurine Use in Korean Patients With Moderate-to-Severe Ulcerative Colitis
  Hye Kyung Hyun, Ji Won Kim, Jun Lee, Yoon Tae Jeen, Tae-Oh Kim, Joo Sung Kim, Jae Jun Park, SungNoh Hong, Dong Il Park, Hyun-Soo Kim, YooJin Lee, Eun Suk Jung, Youngdoe Kim, Su Young Jung, Jae Hee Cheon
  Journal of Clinical Gastroenterology.2025; 59(8): 765.     CrossRef
• Optimizing 5-aminosalicylate for moderate ulcerative colitis: expert recommendations from the Asia-Pacific, Middle East, and Africa Inflammatory Bowel Disease Coalition
  Filiz Akyüz, Yoon Kyo An, Jakob Begun, Satimai Aniwan, Huu Hoang Bui, Webber Chan, Chang Hwan Choi, Nazeer Chopdat, Susan J Connor, Devendra Desai, Emma Flanagan, Taku Kobayashi, Allen Yu-Hung Lai, Rupert W Leong, Alex Hwong-Ruey Leow, Wai Keung Leung, Ju
  Intestinal Research.2025; 23(1): 37.     CrossRef
• Characteristics and outcomes of portal vein thrombosis in patients with inflammatory bowel disease in Korea
  Ki Jin Kim, Su-Bin Song, Jung-Bin Park, June Hwa Bae, Ji Eun Baek, Ga Hee Kim, Min-Jun Kim, Seung Wook Hong, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Chang Sik Yu, Yong-Sik Yoon, Jong-Lyul Lee, Min Hy
  The Korean Journal of Internal Medicine.2025; 40(2): 243.     CrossRef
• Comparison of 1‐Year Clinical Course in Patients With Newly Diagnosed Inflammatory Bowel Disease Between Vietnam and Korea: A Multinational, Multicenter Retrospective Cohort Study
  Luan Minh Dang, Eun Soo Kim, Kyeong Ok Kim, Yoo Jin Lee, Hoang Huu Bui, Chuong Dinh Nguyen, Chi Thi Nguyen, Nam Hoai Nguyen, Hien Thi‐Thu Nguyen, Nga Thi Dinh, Lien Thi‐Phuong Nguyen, Khien Van Vu, Minh Cuong Duong
  JGH Open.2025;[Epub]     CrossRef
• Temporal trends in obesity and its prognostic impact in Korean patients with inflammatory bowel disease
  Min Kyu Kim, Seung Hwan Shin, Cheol-Hyung Lee, Soyoung Kim, Jong Whan Kim, Songhyun Lee, Seung Wook Hong, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sung Wook Hwang
  Journal of Gastroenterology.2025; 60(5): 583.     CrossRef
• Metabolic musculoskeletal disorders in patients with inflammatory bowel disease
  Young Joo Yang, Seong Ran Jeon
  The Korean Journal of Internal Medicine.2025; 40(2): 181.     CrossRef
• Annual Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease During Infliximab Maintenance Therapy: Balancing Efficacy with Risk of Pharmacokinetic Failure
  Yujin Lim, Boram Park, Kyeongman Jeon, Ok Soon Jeong, Eun Ran Kim, Young-Ho Kim, Dong Kyung Chang, Sung Noh Hong
  Digestive Diseases and Sciences.2025; 70(8): 2804.     CrossRef
• Impact of early aggressive treatment on long-term biochemical marker patterns in inflammatory bowel disease
  Yu Kyung Jun, Yonghoon Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, Soyeon Ahn, Hyuk Yoon
  Journal of Gastroenterology.2025; 60(7): 854.     CrossRef
• Population Pharmacokinetic Model for the Use of Intravenous or Subcutaneous Infliximab in Patients with Inflammatory Bowel Disease: Real-World Data from a Prospective Cohort Study
  Joo Hye Song, Sung Noh Hong, Myeong Gyu Kim, Minjung Kim, Seong Kyung Kim, Eun Ran Kim, Dong Kyung Chang, Young-Ho Kim
  Gut and Liver.2025; 19(3): 376.     CrossRef
• Optimizing Infliximab Use in Real-World Inflammatory Bowel Disease: Insights from a Population Pharmacokinetic Model Integrating Intravenous and Subcutaneous Formulations
  Sung Hoon Jung, Sang-Bum Kang
  Gut and Liver.2025; 19(3): 299.     CrossRef
• Does statin have a chemopreventive effect in patients with ulcerative colitis?
  Yoon Suk Jung
  Intestinal Research.2025; 23(2): 113.     CrossRef
• Herpes zoster infection in patients with inflammatory bowel disease
  Dong Hyun Kim, Sang-Bum Kang
  The Korean Journal of Internal Medicine.2025; 40(3): 347.     CrossRef
• Parishin from Gastrodia elata ameliorates DSS induced colitis and anxiety-like behavior in mice by regulating intestinal barrier function and microviota-gut-brain axis
  Xiaoxue Liu, Hejiang Zhou, Na Yang, Lu-Jun Yang, Zheng-Ying Zi, Ya-Lan Han, Jinsong He, Ling-Yan Su
  Phytomedicine.2025; 145: 157019.     CrossRef
• Investigating the pathways for development and registration of biologics in MIST countries
  Nidhi Kansara, Hiral Dave
  Journal of Research in Pharmacy.2025; 29(6): 2287.     CrossRef
• Tofacitinib in acute severe ulcerative colitis: review addressing seven key unmet needs
  Chuong Dinh Nguyen, Luan Minh Dang, Thong Duy Vo, Hoang Huu Bui, Eun Soo Kim, Joyce Wing Yan Mak, Choon Jin Ooi
  Therapeutic Advances in Gastroenterology.2025;[Epub]     CrossRef
• User-needs based app for patients with inflammatory bowel disease: development and usability study
  Mijeong Park, Jisan Lee, Jae Hee Cheon, Nagyeom Yoon, Junghan Yu, Hyoseung Nam
  BMC Health Services Research.2025;[Epub]     CrossRef
• Long‐term effects of ustekinumab in children with inflammatory bowel disease: A systematic review
  Breno Oliveira Marques, Ana Beatriz Ferreira Gusmão, Ana Luiza Ferreira Gusmão, Bianca Ferraz de Almeida Silva, Gabrielle Silva Sousa, Jessica Sabrina Gonçalves Fernandes, Nikolas Brayan da Silva Bragas, Natalia Oliveira e Silva
  Journal of Pediatric Gastroenterology and Nutrition.2025; 81(4): 1045.     CrossRef
• A real-world comparison of subcutaneous to intravenous administration of infliximab in patients with inflammatory bowel disease
  Kwang Woo Kim, Hyoun Woo Kang, Seong-Joon Koh, Hyuk Yoon, Sihyun Kim, Yukyung Jun, Hyun Jung Lee, Jong Pil Im, Young Soo Park, Ji Won Kim, Joo Sung Kim
  Intestinal Research.2025; 23(4): 483.     CrossRef
• Prevalence and risk factors of gallstone disease in Korean patients with ulcerative colitis
  Kwangwoo Nam, Jae Yong Lee, Sang Hyoung Park, Ha Won Hwang, Ho-Su Lee, Kyunghwan Oh, Hee Seung Hong, Kyuwon Kim, Jin Hwa Park, Seung Wook Hong, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang
  Intestinal Research.2025; 23(4): 455.     CrossRef
• Three Janus kinase inhibitors in ulcerative colitis: is upadacitinib taking the lead?
  Yoon Suk Jung
  Intestinal Research.2025; 23(4): 394.     CrossRef
• Ten-Year Trend in 5-Aminosalicylic Acid Prescription Patterns and Treatment Outcomes in Patients with Ulcerative Colitis: An Analysis of Korean Health Insurance Data
  Soo Jung Park, Sang Won Park, Jae Hee Cheon
  Digestive Diseases and Sciences.2025;[Epub]     CrossRef
• Impact of age at diagnosis on long‐term prognosis in patients with intestinal Behçet's disease
  Ji Young Chang, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Hee Cheon, Jihye Park
  Journal of Gastroenterology and Hepatology.2024; 39(3): 519.     CrossRef
• Factors Associated with Reaching Mid-Parental Height in Patients Diagnosed with Inflammatory Bowel Disease in Childhood and Adolescent Period
  So Yoon Choi, Sujin Choi, Byung-Ho Choe, Jae Hong Park, Kwang-Hae Choi, Hae Jeong Lee, Ji Sook Park, Ji-Hyun Seo, Jae Young Kim, Hyo-Jeong Jang, Suk Jin Hong, Eun Young Kim, Yeoun Joo Lee, Ben Kang
  Gut and Liver.2024; 18(1): 106.     CrossRef
• Continued JAK inhibitor treatment on the risk of recurrent herpes zoster reactivation in patients with immune-mediated inflammatory diseases: A nationwide population-based study in South Korea
  Young-Eun Kim, Ye-Jee Kim, Dae Hyun Jeong, Seonok Kim, Min Jee Kim, Hyeon Hwa Kim, Kyung-Wook Jo, Sang Hyoung Park, Seokchan Hong
  Seminars in Arthritis and Rheumatism.2024; 65: 152362.     CrossRef
• Predictors of histologic remission in patients with biologic-naïve, moderate-to-severe ulcerative colitis treated with first-line biologic agents and small-molecule drugs: a single-center, retrospective cohort study
  Kijae Jo, Kwang Woo Kim, Hyun Jung Lee, Jong Pil Im, Joo Sung Kim, Seong-Joon Koh
  Intestinal Research.2024; 22(4): 453.     CrossRef
• Risk Factors of Pneumocystis jirovecii Pneumonia in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study
  Jiyoung Yoon, Seung Wook Hong, Kyung-Do Han, Seung-Woo Lee, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, Joo Sung Kim, Hyuk Yoon
  Gut and Liver.2024; 18(3): 489.     CrossRef
• Optimal Treatment Approaches to Intestinal Behçet's Disease Complicated by Myelodysplastic Syndrome: The KASID and KSBD Multicenter Study
  Jung-Bin Park, So Jung Han, Seung Bum Lee, Dong Hyun Kim, Jae Hee Cheon, Sung Wook Hwang, Byong Duk Ye, Suk-Kyun Yang, Soo Jung Park, Sang Hyoung Park
  Yonsei Medical Journal.2024; 65(5): 265.     CrossRef
• Is the writing on the wall? The relationship between the number of disease-modifying anti-inflammatory bowel disease drugs used and the risk of surgical resection
  Marc M. Mankarious, Alicia C. Greene, Eric W. Schaefer, Kofi Clarke, Afif N. Kulaylat, Nimalan A. Jeganathan, Michael J. Deutsch, Audrey S. Kulaylat
  Journal of Gastrointestinal Surgery.2024; 28(6): 836.     CrossRef
• Clinical Significance of Prognostic Nutrition Index in Patients with Crohn’s Disease after Primary Bowel Resection
  Hyeon Woo Bae, Yong Joon Lee, Min Young Park, Seung Yoon Yang, Yoon Dae Han, Min Soo Cho, Hyuk Hur, Kang Young Lee, Jae Hee Cheon, Joseph C. Carmichael, Byung Soh Min
  Yonsei Medical Journal.2024; 65(7): 380.     CrossRef
• Current Management of Acute Severe Ulcerative Colitis: New Insights on the Surgical Approaches
  Sara Lauricella, Francesco Brucchi, Federica Cavalcoli, Emanuele Rausa, Diletta Cassini, Michelangelo Miccini, Marco Vitellaro, Roberto Cirocchi, Gianluca Costa
  Journal of Personalized Medicine.2024; 14(6): 580.     CrossRef
• Effectiveness of Switching to Subcutaneous Infliximab in Ulcerative Colitis Patients Experiencing Intravenous Infliximab Failure
  June Hwa Bae, Jung-Bin Park, Ji Eun Baek, Seung Wook Hong, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sung Wook Hwang
  Gut and Liver.2024; 18(4): 667.     CrossRef
• Biosimilars in the Era of Artificial Intelligence—International Regulations and the Use in Oncological Treatments
  Tomas Gabriel Bas, Vannessa Duarte
  Pharmaceuticals.2024; 17(7): 925.     CrossRef
• Comparative risk of serious infections and tuberculosis in Korean patients with inflammatory bowel disease treated with non-anti-TNF biologics or anti-TNF-α agents: a nationwide population-based cohort study
  Min Jee Kim, Ye-Jee Kim, Daehyun Jeong, Seonok Kim, Seokchan Hong, Sang Hyoung Park, Kyung-Wook Jo
  Therapeutic Advances in Gastroenterology.2024;[Epub]     CrossRef
• Development and Assessment of a Novel Ulcerative Colitis–Specific Quality of Life Questionnaire: A Prospective, Multi-Institutional Study
  Jihye Park, Hyun-Soo Zhang, Chung Mo Nam, Joo Sung Kim, Young-Ho Kim, Dong Il Park, Byong Duk Ye, Yoon Tae Jeen, Sehyun Kim, Jae Hee Cheon
  Yonsei Medical Journal.2024; 65(11): 636.     CrossRef
• Prevalence and risk factors for gallstone and renal stone formation in patients with intestinal Behçet’s disease
  Jaewon Song, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jihye Park, Jae Hee Cheon
  The Korean Journal of Internal Medicine.2024; 39(5): 770.     CrossRef
• Safety and effectiveness of tofacitinib in Korean adult patients with ulcerative colitis: post-marketing surveillance study
  Hyuk Yoon, Byong Duk Ye, Sang-Bum Kang, Kang-Moon Lee, Chang Hwan Choi, Joo-young Jo, Juwon Woo, Jae Hee Cheon
  BMC Gastroenterology.2024;[Epub]     CrossRef
• Efficacy of Second-Line Biological Therapies in Moderate to Severe Ulcerative Colitis Patients with Prior Failure of Anti-Tumor Necrosis Factor Therapy: A Multi-Center Study
  Ji-Eun Na, Yong-Eun Park, Jong-Ha Park, Tae-Oh Kim, Jong-Yoon Lee, Jong-Hoon Lee, Su-Bum Park, Seung-Bum Lee, Seung-Min Hong
  Journal of Personalized Medicine.2024; 14(10): 1066.     CrossRef
• Ganjiang Huangqin Huanglian Renshen Decoction protects against ulcerative colitis by modulating inflammation, oxidative stress, and gut microbiota
  Ce Zhou, Bo Peng, Mingxing Zhang, Yang Yang, Zelin Yi, Yinghua Wu
  Phytomedicine.2024; 135: 156172.     CrossRef
• The role and prospect of tofacitinib in patients with ulcerative colitis
  Jun Lee
  Intestinal Research.2023; 21(1): 168.     CrossRef
• Real-life effectiveness and safety of tofacitinib treatment in patients with ulcerative colitis: a KASID multicenter cohort study
  Seung Hwan Shin, Kyunghwan Oh, Sung Noh Hong, Jungbok Lee, Shin Ju Oh, Eun Soo Kim, Soo-Young Na, Sang-Bum Kang, Seong-Joon Koh, Ki Bae Bang, Sung-Ae Jung, Sung Hoon Jung, Kyeong Ok Kim, Sang Hyoung Park, Suk-Kyun Yang, Chang Hwan Choi, Byong Duk Ye
  Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
• Safety of Biologic Therapy in Older Adults with Inflammatory Bowel Diseases
  Tae-Geun Gweon
  The Korean Journal of Gastroenterology.2023; 81(5): 230.     CrossRef
• Risk of all-cause and cause-specific mortality associated with immune-mediated inflammatory diseases in Korea
  Oh Chan Kwon, See Young Lee, Jaeyoung Chun, Kyungdo Han, Yuna Kim, Ryul Kim, Min-Chan Park, Jie-Hyun Kim, Young Hoon Youn, Hyojin Park
  Frontiers in Medicine.2023;[Epub]     CrossRef
• How have treatment patterns for patients with inflammatory bowel disease changed in Asian countries?
  Jihye Park
  Intestinal Research.2023; 21(3): 275.     CrossRef
• Treatment of primary sclerosing cholangitis combined with inflammatory bowel disease
  You Sun Kim, Edward H. Hurley, Yoojeong Park, Sungjin Ko
  Intestinal Research.2023; 21(4): 420.     CrossRef
• Characteristics and Treatment Outcomes of Transition among Patients with Inflammatory Bowel Disease
  Eun Jin Yoo, Sang-Hoon Cho, Soo Jung Park, Tae Il Kim, Won Ho Kim, Jae Hee Cheon
  Yonsei Medical Journal.2023; 64(9): 541.     CrossRef
• 10 years of biologic use patterns in patients with inflammatory bowel disease: treatment persistence, switching and dose intensification – a nationwide population-based study
  Hee Moon Koo, Yu Kyung Jun, Yonghoon Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, Young Kee Shin, Hyuk Yoon
  Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
• Network meta-analysis on efficacy and safety of different biologics for ulcerative colitis
  Xinqiao Chu, Yaning Biao, Chengjiang Liu, Yixin Zhang, Chenxu Liu, Ji-zheng Ma, Yufeng Guo, Yaru Gu
  BMC Gastroenterology.2023;[Epub]     CrossRef
• Advancements in the Management of Moderate-to-Severe Ulcerative Colitis: A Revised 2023 Korean Treatment Guidelines
  Soo-Young Na
  The Korean Journal of Medicine.2023; 98(5): 223.     CrossRef
• IBD barriers across the continents – East Asia
  Joyce Wing Yan Mak, Agnes Hiu Yan Ho, Siew Chien Ng
  Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
• Evaluation of Bacterial and Fungal Biomarkers for Differentiation and Prognosis of Patients with Inflammatory Bowel Disease
  Hyuk Yoon, Sunghyouk Park, Yu Kyung Jun, Yonghoon Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee
  Microorganisms.2023; 11(12): 2882.     CrossRef
• “Theranekron: A Novel Anti-inflammatory Candidate for Acetic Acid-Induced Colonic Inflammation in Rats”
  Mehtap Savran, Halil Ascı, Yalcin Erzurumlu, Ozlem Ozmen, Ilter Ilhan, M. Cem Sırın, Nasif Fatih Karakuyu, Adnan Karaibrahimoglu
  Molecular Biology Reports.2022; 49(9): 8753.     CrossRef